Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
-36,62%
5-year Growth Rate
R
2/5
5-year Risk Analysis
O
N/A
Outlook 12/26
W
-10,76%
Margin of safety
T
455%
Analyst Price Target
H
DOWN
50-week EMA Trend
Company Info
EPS Growth 5Y
-169,82%
Revenue growth 5Y
189,70%
Price growth 5Y
1541,18%
Market Cap
₪0,02 B
Long-Term Debt
₪0,00 B
Quarterly earnings
11/27/2026
Dividend
₪0,00
Dividend Yield
0,00%
Industry
Country
Website
ISIN Number
Can-Fite BioPharma Price Chart (ILS)
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
₪14,59
454.75%
Last Update: 10/29/2026
Analysts: 1
Highest Price Target ₪14,59
Average Price Target ₪14,59
Lowest Price Target ₪14,59
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Can-Fite BioPharma
TASE:CANF
|
1541,18% | 1541,18% | 0,00% | -36,62% | 2/5 | -100,00% | -10,76% | 452,65% | DOWN |
